Literature DB >> 31157276

Coming of age of bevacizumab in the management of radiation-induced cerebral necrosis.

Melvin L K Chua1,2,3, Kevin L M Chua1,3, Joseph T S Wee1,3.   

Abstract

Entities:  

Year:  2019        PMID: 31157276      PMCID: PMC6511557          DOI: 10.21037/atm.2019.03.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  1 in total

1.  Neutrophil to lymphocyte ratio as a predictor for treatment of radiation-induced brain necrosis with bevacizumab in nasopharyngeal carcinoma patients.

Authors:  Jinhua Cai; Ruiqi Xue; Zongwei Yue; Zhan Zhang; Lei He; Honghong Li; Yi Li; Xiaoming Rong; Xiaoni Zhang; Yongteng Xu; Yamei Tang
Journal:  Clin Transl Med       Date:  2022-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.